Answers are grounded in this paper and cite their sources.
Registry cohort study demonstrates increased skin infection rates without overall serious infection elevation in rheumatoid arthritis, highlighting tissue-specific immune defense roles.
In patients with active RA, anti-TNF therapy was not associated with increased risk of overall serious infection compared with DMARD treatment, after adjustment for baseline risk. In contrast, the rate of serious skin and soft tissue infections was increased, suggesting an important physiologic role of TNF in host defense in the skin and soft tissues beyond that in other tissues.
No takes yet. Share an insight, caveat, or question.
Dixon et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: